Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening
Recruiting
New York University School of Medicine
Phase 3
2020-07-15
Attention-deficit/hyperactivity disorder (ADHD) is a neuropsychiatric disorder characterized
by problems with sustaining attention, organization, planning, procrastination, daydreaming,
restlessness, impulsivity and hyperactivity.This is an outpatient study for subjects between
the ages of 18-60, who have an Attention deficit hyperactivity disorder (ADHD) diagnosis
meeting all inclusion criteria and not meeting any of the exclusion criteria.
Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening
Recruiting
NYU Langone Health
Phase 3
2020-07-15
Attention-deficit/hyperactivity disorder (ADHD) is a neuropsychiatric disorder characterized
by problems with sustaining attention, organization, planning, procrastination, daydreaming,
restlessness, impulsivity and hyperactivity.This is an outpatient study for subjects between
the ages of 18-60, who have an Attention deficit hyperactivity disorder (ADHD) diagnosis
meeting all inclusion criteria and not meeting any of the exclusion criteria.
8 Week Multi-site Study of MYDAYIS® for Bipolar Depression
Recruiting
Lindner Center of HOPE
Phase 2
2020-07-17
This protocol is a Phase 2 multi-site study which aims to evaluate the safety and
effectiveness of MYDAYIS® as adjunctive therapy for adults with bipolar depression.
Results from this study WILL NOT be used to contribute to an approval of MYDAYIS ® for
this indication.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
